The visualization and quantifications, moreover, can be applied to clinical investigations of choroid-related pathologies other than CSC and VKH/SO, and these include AMD (where the efficacy of treatments such as anti-VEGF injections could be tracked) and pathological myopia, where the value of various therapeutic interventions could be evaluated. This evidence concerns the gene VEGFA and age-related macular degeneration.